Literature DB >> 9010531

Transcranial color-coded duplex sonography in the evaluation of collateral flow through the circle of Willis.

R W Baumgartner1, I Baumgartner, H P Mattle, G Schroth.   

Abstract

PURPOSE: To determine the sensitivity, specificity, and positive and negative predictive values of transcranial color-coded duplex sonographic (TCCD) evaluation of cross flow through the anterior (ACoA) and posterior (PCoA) communicating arteries in patients with occlusive cerebrovascular disease.
METHODS: We studied prospectively 132 patients (37 women, 95 men; mean age, 60 years) with stenoses of more than 69% reduction in vessel diameter (n = 93) and occlusions (n = 52) of the internal carotid artery, and three occlusions of the basilar artery. The sonographer was aware of extracranial sonographic findings but was blinded to the results of cerebral angiography.
RESULTS: Nine patients (7%) with thick bones preventing transtemporal insonation and three patients (3%) with occlusions of the middle (n = 3) and anterior (n = 1) cerebral arteries were excluded. Sensitivity of TCCD for detection of collateral flow through the ACoA in patients with occlusive carotid artery disease was 98%, specificity was 100%, positive predictive value was 100%, and negative predictive value was 98%. The corresponding values for the PCoA were 84%, 94%, 94%, and 84%, respectively. All three functional PCoAs were identified in patients with occluded basilar arteries.
CONCLUSION: TCCD is a valuable method for noninvasive evaluation of cross flow through the ACoA in patients with adequate sonographic windows. However, TCCD evaluation of cross flow through the PCoA is less reliable, because hemodynamic criteria may cause falsely positive and falsely negative results.

Entities:  

Mesh:

Year:  1997        PMID: 9010531      PMCID: PMC8337872     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

1.  Assessment of the collateral function of the circle of Willis: three-dimensional time-of-flight MR angiography compared with transcranial color-coded duplex sonography.

Authors:  Arjan W J Hoksbergen; Charles B L Majoie; Frans-Jan H Hulsmans; Dink A Legemate
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

2.  Echo-enhanced transcranial color-coded duplex sonography in the diagnosis of cerebrovascular events: a validation study.

Authors:  A Kunz; G Hahn; D Mucha; A Müller; K M Barrett; R von Kummer; G Gahn
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

3.  Color Doppler ultrasonography for predicting the patency of anastomosis after superficial temporal to middle cerebral artery bypass surgery.

Authors:  Jang Hun Kim; Sung-Kon Ha; Sung-Won Jin; Hae-Bin Lee; Sang-Dae Kim; Se-Hoon Kim; Dong-Jun Lim
Journal:  Acta Neurochir (Wien)       Date:  2021-01-06       Impact factor: 2.216

4.  Contrast-enhanced transcranial Doppler sonography in the follow-up of intracranial aneurysms after endovascular treatment.

Authors:  A Cordebar; S Bracard; S Kremer; E Schmitt; R Anxionnat; A Martin-Bertaux; L Picard
Journal:  Neuroradiology       Date:  2004-10-19       Impact factor: 2.804

5.  Relationship between findings of conventional and contrast-enhanced transcranial color-coded real-time sonography and angiography in patients with basilar artery occlusion.

Authors:  Masatoshi Koga; Kazumi Kimura; Kazuo Minematsu; Takenori Yamaguchi
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

6.  Prognosis of asymptomatic stenosis of the middle cerebral artery.

Authors:  C Kremer; T Schaettin; D Georgiadis; R W Baumgartner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

7.  Magnetic resonance angiographic evaluation of circle of Willis: A morphologic study in a tertiary hospital set up.

Authors:  Shankar Rao Naveen; Venkatraman Bhat; Gadabanahalli Ashok Karthik
Journal:  Ann Indian Acad Neurol       Date:  2015 Oct-Dec       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.